Maxcyte, Inc. · NASDAQ:MXCT
BlackRock, Inc. reported a 6.60% stake in Maxcyte, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 6.60% stake in Maxcyte, Inc., 6,997,197 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 6.60%
- Shares
- 6,997,197
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.60% | 6,997,197 |
Source
Related
- Maxcyte, Inc.
- BlackRock, Inc.
- Maxcyte, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Schedule 13D · Liontrust Investment Partners LLP · Oct 15, 2026
- Schedule 13D · River Global Investors LLP · Aug 4, 2026
- Form 4 · Johnston John Joseph · Jun 22, 2026
- Form 4 · Hemrajani Rekha · Jun 22, 2026
- Form 4 · Erck Stanley C · Jun 22, 2026